nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—Skin necrosis—Etoposide—muscle cancer	0.0278	0.0279	CcSEcCtD
Esmolol—Electrocardiogram ST segment depression—Doxorubicin—muscle cancer	0.0222	0.0223	CcSEcCtD
Esmolol—Induration—Etoposide—muscle cancer	0.0217	0.0218	CcSEcCtD
Esmolol—Skin necrosis—Methotrexate—muscle cancer	0.0166	0.0167	CcSEcCtD
Esmolol—Extravasation—Dactinomycin—muscle cancer	0.0154	0.0154	CcSEcCtD
Esmolol—Skin necrosis—Doxorubicin—muscle cancer	0.0144	0.0145	CcSEcCtD
Esmolol—Rales—Methotrexate—muscle cancer	0.0142	0.0142	CcSEcCtD
Esmolol—Extravasation—Vincristine—muscle cancer	0.0137	0.0138	CcSEcCtD
Esmolol—Supraventricular extrasystoles—Doxorubicin—muscle cancer	0.0135	0.0136	CcSEcCtD
Esmolol—Respiratory failure—Vincristine—muscle cancer	0.0122	0.0123	CcSEcCtD
Esmolol—Rigors—Etoposide—muscle cancer	0.0119	0.0119	CcSEcCtD
Esmolol—Neuropathy—Vincristine—muscle cancer	0.0112	0.0113	CcSEcCtD
Esmolol—Extravasation—Etoposide—muscle cancer	0.0111	0.0112	CcSEcCtD
Esmolol—Skin discolouration—Etoposide—muscle cancer	0.0107	0.0108	CcSEcCtD
Esmolol—Pneumothorax—Doxorubicin—muscle cancer	0.0101	0.0102	CcSEcCtD
Esmolol—Inflammation—Etoposide—muscle cancer	0.01	0.0101	CcSEcCtD
Esmolol—Skin exfoliation—Etoposide—muscle cancer	0.00927	0.00931	CcSEcCtD
Esmolol—Psoriasis—Methotrexate—muscle cancer	0.00925	0.0093	CcSEcCtD
Esmolol—Neuropathy—Etoposide—muscle cancer	0.00911	0.00916	CcSEcCtD
Esmolol—Cardiac arrest—Vincristine—muscle cancer	0.00827	0.00831	CcSEcCtD
Esmolol—Urinary retention—Vincristine—muscle cancer	0.00827	0.00831	CcSEcCtD
Esmolol—Psoriasis—Doxorubicin—muscle cancer	0.00801	0.00805	CcSEcCtD
Esmolol—Cardiac failure congestive—Etoposide—muscle cancer	0.00777	0.00781	CcSEcCtD
Esmolol—Pleural effusion—Methotrexate—muscle cancer	0.00759	0.00763	CcSEcCtD
Esmolol—Cardiac failure—Etoposide—muscle cancer	0.00722	0.00726	CcSEcCtD
Esmolol—Dysuria—Vincristine—muscle cancer	0.00703	0.00707	CcSEcCtD
Esmolol—Blister—Doxorubicin—muscle cancer	0.00698	0.00702	CcSEcCtD
Esmolol—Speech disorder—Methotrexate—muscle cancer	0.00676	0.00679	CcSEcCtD
Esmolol—Cardiac arrest—Etoposide—muscle cancer	0.0067	0.00673	CcSEcCtD
Esmolol—Pharyngitis—Dactinomycin—muscle cancer	0.00668	0.00672	CcSEcCtD
Esmolol—Extravasation—Methotrexate—muscle cancer	0.00666	0.0067	CcSEcCtD
Esmolol—Acute coronary syndrome—Vincristine—muscle cancer	0.00661	0.00664	CcSEcCtD
Esmolol—Pleural effusion—Doxorubicin—muscle cancer	0.00657	0.00661	CcSEcCtD
Esmolol—Myocardial infarction—Vincristine—muscle cancer	0.00657	0.0066	CcSEcCtD
Esmolol—Neuropathy peripheral—Vincristine—muscle cancer	0.00657	0.0066	CcSEcCtD
Esmolol—Skin discolouration—Methotrexate—muscle cancer	0.00644	0.00647	CcSEcCtD
Esmolol—Oliguria—Methotrexate—muscle cancer	0.00631	0.00634	CcSEcCtD
Esmolol—Flushing—Dactinomycin—muscle cancer	0.00625	0.00628	CcSEcCtD
Esmolol—Rigors—Doxorubicin—muscle cancer	0.00617	0.0062	CcSEcCtD
Esmolol—Chills—Dactinomycin—muscle cancer	0.00604	0.00607	CcSEcCtD
Esmolol—Inflammation—Methotrexate—muscle cancer	0.00599	0.00602	CcSEcCtD
Esmolol—Bronchospasm—Etoposide—muscle cancer	0.00599	0.00602	CcSEcCtD
Esmolol—Urinary tract disorder—Vincristine—muscle cancer	0.00594	0.00597	CcSEcCtD
Esmolol—Sweating increased—Etoposide—muscle cancer	0.00593	0.00596	CcSEcCtD
Esmolol—Respiratory failure—Methotrexate—muscle cancer	0.00592	0.00595	CcSEcCtD
Esmolol—Urethral disorder—Vincristine—muscle cancer	0.0059	0.00593	CcSEcCtD
Esmolol—Erythema—Dactinomycin—muscle cancer	0.00586	0.00589	CcSEcCtD
Esmolol—Extravasation—Doxorubicin—muscle cancer	0.00577	0.0058	CcSEcCtD
Esmolol—Cardiac disorder—Vincristine—muscle cancer	0.00558	0.00561	CcSEcCtD
Esmolol—Ventricular extrasystoles—Doxorubicin—muscle cancer	0.00557	0.0056	CcSEcCtD
Esmolol—Skin discolouration—Doxorubicin—muscle cancer	0.00557	0.0056	CcSEcCtD
Esmolol—Skin exfoliation—Methotrexate—muscle cancer	0.00555	0.00558	CcSEcCtD
Esmolol—Thinking abnormal—Doxorubicin—muscle cancer	0.0055	0.00553	CcSEcCtD
Esmolol—Oliguria—Doxorubicin—muscle cancer	0.00546	0.00549	CcSEcCtD
Esmolol—Angiopathy—Vincristine—muscle cancer	0.00546	0.00549	CcSEcCtD
Esmolol—Acute coronary syndrome—Etoposide—muscle cancer	0.00535	0.00538	CcSEcCtD
Esmolol—Myocardial infarction—Etoposide—muscle cancer	0.00532	0.00535	CcSEcCtD
Esmolol—Neuropathy peripheral—Etoposide—muscle cancer	0.00532	0.00535	CcSEcCtD
Esmolol—Mental disorder—Vincristine—muscle cancer	0.00527	0.0053	CcSEcCtD
Esmolol—Ecchymosis—Methotrexate—muscle cancer	0.00526	0.00528	CcSEcCtD
Esmolol—Inflammation—Doxorubicin—muscle cancer	0.00519	0.00522	CcSEcCtD
Esmolol—Atrioventricular block—Doxorubicin—muscle cancer	0.00519	0.00522	CcSEcCtD
Esmolol—Pulmonary oedema—Methotrexate—muscle cancer	0.00517	0.0052	CcSEcCtD
Esmolol—Thrombophlebitis—Methotrexate—muscle cancer	0.00487	0.0049	CcSEcCtD
Esmolol—Urinary tract disorder—Etoposide—muscle cancer	0.00481	0.00484	CcSEcCtD
Esmolol—Agitation—Vincristine—muscle cancer	0.00481	0.00484	CcSEcCtD
Esmolol—Skin exfoliation—Doxorubicin—muscle cancer	0.00481	0.00483	CcSEcCtD
Esmolol—Oedema—Dactinomycin—muscle cancer	0.00478	0.00481	CcSEcCtD
Esmolol—Urethral disorder—Etoposide—muscle cancer	0.00478	0.0048	CcSEcCtD
Esmolol—Neuropathy—Doxorubicin—muscle cancer	0.00473	0.00475	CcSEcCtD
Esmolol—Anorexia—Dactinomycin—muscle cancer	0.00456	0.00458	CcSEcCtD
Esmolol—Ecchymosis—Doxorubicin—muscle cancer	0.00455	0.00457	CcSEcCtD
Esmolol—Convulsion—Vincristine—muscle cancer	0.00454	0.00456	CcSEcCtD
Esmolol—Cardiac disorder—Etoposide—muscle cancer	0.00452	0.00455	CcSEcCtD
Esmolol—Flushing—Etoposide—muscle cancer	0.00452	0.00455	CcSEcCtD
Esmolol—Pulmonary oedema—Doxorubicin—muscle cancer	0.00448	0.0045	CcSEcCtD
Esmolol—Angiopathy—Etoposide—muscle cancer	0.00442	0.00444	CcSEcCtD
Esmolol—Abnormal vision—Doxorubicin—muscle cancer	0.00439	0.00441	CcSEcCtD
Esmolol—Chills—Etoposide—muscle cancer	0.00437	0.0044	CcSEcCtD
Esmolol—Mental disability—Doxorubicin—muscle cancer	0.00437	0.00439	CcSEcCtD
Esmolol—Oedema—Vincristine—muscle cancer	0.00427	0.0043	CcSEcCtD
Esmolol—Thrombophlebitis—Doxorubicin—muscle cancer	0.00422	0.00424	CcSEcCtD
Esmolol—Nervous system disorder—Vincristine—muscle cancer	0.00419	0.00421	CcSEcCtD
Esmolol—Decreased appetite—Dactinomycin—muscle cancer	0.00416	0.00418	CcSEcCtD
Esmolol—Dysgeusia—Etoposide—muscle cancer	0.00415	0.00418	CcSEcCtD
Esmolol—Hyperhidrosis—Vincristine—muscle cancer	0.00413	0.00415	CcSEcCtD
Esmolol—Fatigue—Dactinomycin—muscle cancer	0.00412	0.00415	CcSEcCtD
Esmolol—Pain—Dactinomycin—muscle cancer	0.00409	0.00411	CcSEcCtD
Esmolol—Anorexia—Vincristine—muscle cancer	0.00407	0.0041	CcSEcCtD
Esmolol—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00403	0.00405	CcSEcCtD
Esmolol—Irritability—Methotrexate—muscle cancer	0.00403	0.00405	CcSEcCtD
Esmolol—Hypotension—Vincristine—muscle cancer	0.00399	0.00402	CcSEcCtD
Esmolol—Feeling abnormal—Dactinomycin—muscle cancer	0.00394	0.00396	CcSEcCtD
Esmolol—Paraesthesia—Vincristine—muscle cancer	0.00384	0.00386	CcSEcCtD
Esmolol—Dermatitis bullous—Doxorubicin—muscle cancer	0.00382	0.00384	CcSEcCtD
Esmolol—Body temperature increased—Dactinomycin—muscle cancer	0.00378	0.0038	CcSEcCtD
Esmolol—Cardiac failure—Doxorubicin—muscle cancer	0.00374	0.00376	CcSEcCtD
Esmolol—Loss of consciousness—Etoposide—muscle cancer	0.00373	0.00375	CcSEcCtD
Esmolol—Decreased appetite—Vincristine—muscle cancer	0.00372	0.00374	CcSEcCtD
Esmolol—Gastrointestinal disorder—Vincristine—muscle cancer	0.00369	0.00371	CcSEcCtD
Esmolol—Fatigue—Vincristine—muscle cancer	0.00369	0.0037	CcSEcCtD
Esmolol—Convulsion—Etoposide—muscle cancer	0.00368	0.0037	CcSEcCtD
Esmolol—Constipation—Vincristine—muscle cancer	0.00366	0.00367	CcSEcCtD
Esmolol—Pain—Vincristine—muscle cancer	0.00366	0.00367	CcSEcCtD
Esmolol—Chest pain—Etoposide—muscle cancer	0.00361	0.00363	CcSEcCtD
Esmolol—Chlorphenesin—PTGS2—muscle cancer	0.0036	0.691	CrCbGaD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00359	0.00361	CcSEcCtD
Esmolol—Abdominal discomfort—Methotrexate—muscle cancer	0.0035	0.00351	CcSEcCtD
Esmolol—Confusional state—Etoposide—muscle cancer	0.00349	0.00351	CcSEcCtD
Esmolol—Cardiac arrest—Doxorubicin—muscle cancer	0.00347	0.00349	CcSEcCtD
Esmolol—Asthenia—Dactinomycin—muscle cancer	0.00343	0.00345	CcSEcCtD
Esmolol—Dysuria—Methotrexate—muscle cancer	0.00341	0.00343	CcSEcCtD
Esmolol—Body temperature increased—Vincristine—muscle cancer	0.00338	0.0034	CcSEcCtD
Esmolol—Skin disorder—Etoposide—muscle cancer	0.00336	0.00338	CcSEcCtD
Esmolol—Hyperhidrosis—Etoposide—muscle cancer	0.00335	0.00336	CcSEcCtD
Esmolol—Anorexia—Etoposide—muscle cancer	0.0033	0.00332	CcSEcCtD
Esmolol—Nasopharyngitis—Doxorubicin—muscle cancer	0.00327	0.00328	CcSEcCtD
Esmolol—Drowsiness—Methotrexate—muscle cancer	0.00325	0.00327	CcSEcCtD
Esmolol—Hypotension—Etoposide—muscle cancer	0.00324	0.00325	CcSEcCtD
Esmolol—Paraesthesia—Etoposide—muscle cancer	0.00311	0.00313	CcSEcCtD
Esmolol—Dyspnoea—Etoposide—muscle cancer	0.00309	0.0031	CcSEcCtD
Esmolol—Somnolence—Etoposide—muscle cancer	0.00308	0.00309	CcSEcCtD
Esmolol—Angina pectoris—Doxorubicin—muscle cancer	0.00308	0.00309	CcSEcCtD
Esmolol—Asthenia—Vincristine—muscle cancer	0.00307	0.00308	CcSEcCtD
Esmolol—Vomiting—Dactinomycin—muscle cancer	0.00304	0.00306	CcSEcCtD
Esmolol—Decreased appetite—Etoposide—muscle cancer	0.00301	0.00303	CcSEcCtD
Esmolol—Gastrointestinal disorder—Etoposide—muscle cancer	0.00299	0.003	CcSEcCtD
Esmolol—Fatigue—Etoposide—muscle cancer	0.00299	0.003	CcSEcCtD
Esmolol—Pain—Etoposide—muscle cancer	0.00296	0.00298	CcSEcCtD
Esmolol—Constipation—Etoposide—muscle cancer	0.00296	0.00298	CcSEcCtD
Esmolol—Dysuria—Doxorubicin—muscle cancer	0.00295	0.00297	CcSEcCtD
Esmolol—Pharyngitis—Methotrexate—muscle cancer	0.0029	0.00291	CcSEcCtD
Esmolol—Urinary tract disorder—Methotrexate—muscle cancer	0.00288	0.0029	CcSEcCtD
Esmolol—Urethral disorder—Methotrexate—muscle cancer	0.00286	0.00288	CcSEcCtD
Esmolol—Feeling abnormal—Etoposide—muscle cancer	0.00285	0.00287	CcSEcCtD
Esmolol—Nausea—Dactinomycin—muscle cancer	0.00284	0.00286	CcSEcCtD
Esmolol—Dizziness—Vincristine—muscle cancer	0.00283	0.00284	CcSEcCtD
Esmolol—Drowsiness—Doxorubicin—muscle cancer	0.00282	0.00283	CcSEcCtD
Esmolol—Visual impairment—Methotrexate—muscle cancer	0.00281	0.00283	CcSEcCtD
Esmolol—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00276	0.00277	CcSEcCtD
Esmolol—Urticaria—Etoposide—muscle cancer	0.00275	0.00277	CcSEcCtD
Esmolol—Body temperature increased—Etoposide—muscle cancer	0.00274	0.00275	CcSEcCtD
Esmolol—Vomiting—Vincristine—muscle cancer	0.00272	0.00273	CcSEcCtD
Esmolol—Cardiac disorder—Methotrexate—muscle cancer	0.00271	0.00272	CcSEcCtD
Esmolol—Headache—Vincristine—muscle cancer	0.00268	0.00269	CcSEcCtD
Esmolol—Angiopathy—Methotrexate—muscle cancer	0.00265	0.00266	CcSEcCtD
Esmolol—Chills—Methotrexate—muscle cancer	0.00262	0.00263	CcSEcCtD
Esmolol—Bradycardia—Doxorubicin—muscle cancer	0.00257	0.00259	CcSEcCtD
Esmolol—Mental disorder—Methotrexate—muscle cancer	0.00256	0.00257	CcSEcCtD
Esmolol—Erythema—Methotrexate—muscle cancer	0.00254	0.00255	CcSEcCtD
Esmolol—Nausea—Vincristine—muscle cancer	0.00254	0.00255	CcSEcCtD
Esmolol—Rhinitis—Doxorubicin—muscle cancer	0.00253	0.00255	CcSEcCtD
Esmolol—Pharyngitis—Doxorubicin—muscle cancer	0.00251	0.00252	CcSEcCtD
Esmolol—Urinary tract disorder—Doxorubicin—muscle cancer	0.0025	0.00251	CcSEcCtD
Esmolol—Dysgeusia—Methotrexate—muscle cancer	0.00249	0.0025	CcSEcCtD
Esmolol—Asthenia—Etoposide—muscle cancer	0.00248	0.0025	CcSEcCtD
Esmolol—Urethral disorder—Doxorubicin—muscle cancer	0.00248	0.00249	CcSEcCtD
Esmolol—Pruritus—Etoposide—muscle cancer	0.00245	0.00246	CcSEcCtD
Esmolol—Visual impairment—Doxorubicin—muscle cancer	0.00244	0.00245	CcSEcCtD
Esmolol—Flushing—Doxorubicin—muscle cancer	0.00235	0.00236	CcSEcCtD
Esmolol—Cardiac disorder—Doxorubicin—muscle cancer	0.00235	0.00236	CcSEcCtD
Esmolol—Angiopathy—Doxorubicin—muscle cancer	0.00229	0.00231	CcSEcCtD
Esmolol—Dizziness—Etoposide—muscle cancer	0.00229	0.0023	CcSEcCtD
Esmolol—Chills—Doxorubicin—muscle cancer	0.00227	0.00228	CcSEcCtD
Esmolol—Mental disorder—Doxorubicin—muscle cancer	0.00221	0.00223	CcSEcCtD
Esmolol—Convulsion—Methotrexate—muscle cancer	0.0022	0.00221	CcSEcCtD
Esmolol—Vomiting—Etoposide—muscle cancer	0.0022	0.00221	CcSEcCtD
Esmolol—Erythema—Doxorubicin—muscle cancer	0.0022	0.00221	CcSEcCtD
Esmolol—Headache—Etoposide—muscle cancer	0.00217	0.00218	CcSEcCtD
Esmolol—Chest pain—Methotrexate—muscle cancer	0.00216	0.00217	CcSEcCtD
Esmolol—Dysgeusia—Doxorubicin—muscle cancer	0.00215	0.00217	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00215	0.00216	CcSEcCtD
Esmolol—Confusional state—Methotrexate—muscle cancer	0.00209	0.0021	CcSEcCtD
Esmolol—Nausea—Etoposide—muscle cancer	0.00206	0.00207	CcSEcCtD
Esmolol—Nervous system disorder—Methotrexate—muscle cancer	0.00203	0.00204	CcSEcCtD
Esmolol—Agitation—Doxorubicin—muscle cancer	0.00202	0.00203	CcSEcCtD
Esmolol—Skin disorder—Methotrexate—muscle cancer	0.00201	0.00203	CcSEcCtD
Esmolol—Hyperhidrosis—Methotrexate—muscle cancer	0.00201	0.00202	CcSEcCtD
Esmolol—Anorexia—Methotrexate—muscle cancer	0.00198	0.00199	CcSEcCtD
Esmolol—Syncope—Doxorubicin—muscle cancer	0.00197	0.00198	CcSEcCtD
Esmolol—Hypotension—Methotrexate—muscle cancer	0.00194	0.00195	CcSEcCtD
Esmolol—Loss of consciousness—Doxorubicin—muscle cancer	0.00193	0.00194	CcSEcCtD
Esmolol—Convulsion—Doxorubicin—muscle cancer	0.00191	0.00192	CcSEcCtD
Esmolol—Chest pain—Doxorubicin—muscle cancer	0.00187	0.00188	CcSEcCtD
Esmolol—Anxiety—Doxorubicin—muscle cancer	0.00187	0.00188	CcSEcCtD
Esmolol—Paraesthesia—Methotrexate—muscle cancer	0.00186	0.00187	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00186	0.00187	CcSEcCtD
Esmolol—Dyspnoea—Methotrexate—muscle cancer	0.00185	0.00186	CcSEcCtD
Esmolol—Somnolence—Methotrexate—muscle cancer	0.00184	0.00185	CcSEcCtD
Esmolol—Dry mouth—Doxorubicin—muscle cancer	0.00183	0.00184	CcSEcCtD
Esmolol—Dyspepsia—Methotrexate—muscle cancer	0.00183	0.00184	CcSEcCtD
Esmolol—Confusional state—Doxorubicin—muscle cancer	0.00181	0.00182	CcSEcCtD
Esmolol—Decreased appetite—Methotrexate—muscle cancer	0.0018	0.00181	CcSEcCtD
Esmolol—Oedema—Doxorubicin—muscle cancer	0.0018	0.00181	CcSEcCtD
Esmolol—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00179	0.0018	CcSEcCtD
Esmolol—Fatigue—Methotrexate—muscle cancer	0.00179	0.0018	CcSEcCtD
Esmolol—Pain—Methotrexate—muscle cancer	0.00177	0.00178	CcSEcCtD
Esmolol—Shock—Doxorubicin—muscle cancer	0.00177	0.00178	CcSEcCtD
Esmolol—Nervous system disorder—Doxorubicin—muscle cancer	0.00176	0.00177	CcSEcCtD
Esmolol—Skin disorder—Doxorubicin—muscle cancer	0.00174	0.00175	CcSEcCtD
Esmolol—Hyperhidrosis—Doxorubicin—muscle cancer	0.00174	0.00175	CcSEcCtD
Esmolol—Anorexia—Doxorubicin—muscle cancer	0.00171	0.00172	CcSEcCtD
Esmolol—Feeling abnormal—Methotrexate—muscle cancer	0.00171	0.00172	CcSEcCtD
Esmolol—Hypotension—Doxorubicin—muscle cancer	0.00168	0.00169	CcSEcCtD
Esmolol—Urticaria—Methotrexate—muscle cancer	0.00165	0.00166	CcSEcCtD
Esmolol—Body temperature increased—Methotrexate—muscle cancer	0.00164	0.00165	CcSEcCtD
Esmolol—Paraesthesia—Doxorubicin—muscle cancer	0.00161	0.00162	CcSEcCtD
Esmolol—Ibuprofen—PTGS2—muscle cancer	0.00161	0.309	CrCbGaD
Esmolol—Dyspnoea—Doxorubicin—muscle cancer	0.0016	0.00161	CcSEcCtD
Esmolol—Somnolence—Doxorubicin—muscle cancer	0.0016	0.0016	CcSEcCtD
Esmolol—Dyspepsia—Doxorubicin—muscle cancer	0.00158	0.00159	CcSEcCtD
Esmolol—Decreased appetite—Doxorubicin—muscle cancer	0.00156	0.00157	CcSEcCtD
Esmolol—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00155	0.00156	CcSEcCtD
Esmolol—Fatigue—Doxorubicin—muscle cancer	0.00155	0.00156	CcSEcCtD
Esmolol—Constipation—Doxorubicin—muscle cancer	0.00154	0.00154	CcSEcCtD
Esmolol—Pain—Doxorubicin—muscle cancer	0.00154	0.00154	CcSEcCtD
Esmolol—Asthenia—Methotrexate—muscle cancer	0.00149	0.0015	CcSEcCtD
Esmolol—Feeling abnormal—Doxorubicin—muscle cancer	0.00148	0.00149	CcSEcCtD
Esmolol—Pruritus—Methotrexate—muscle cancer	0.00147	0.00148	CcSEcCtD
Esmolol—Urticaria—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Esmolol—Body temperature increased—Doxorubicin—muscle cancer	0.00142	0.00143	CcSEcCtD
Esmolol—Dizziness—Methotrexate—muscle cancer	0.00137	0.00138	CcSEcCtD
Esmolol—Vomiting—Methotrexate—muscle cancer	0.00132	0.00133	CcSEcCtD
Esmolol—Headache—Methotrexate—muscle cancer	0.0013	0.00131	CcSEcCtD
Esmolol—Asthenia—Doxorubicin—muscle cancer	0.00129	0.0013	CcSEcCtD
Esmolol—Pruritus—Doxorubicin—muscle cancer	0.00127	0.00128	CcSEcCtD
Esmolol—Nausea—Methotrexate—muscle cancer	0.00123	0.00124	CcSEcCtD
Esmolol—Dizziness—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Esmolol—Vomiting—Doxorubicin—muscle cancer	0.00114	0.00115	CcSEcCtD
Esmolol—Headache—Doxorubicin—muscle cancer	0.00113	0.00113	CcSEcCtD
Esmolol—Nausea—Doxorubicin—muscle cancer	0.00107	0.00107	CcSEcCtD
